nodes	percent_of_prediction	percent_of_DWPC	metapath
Bepridil—ABCB1—ovarian cancer	0.335	1	CbGaD
Bepridil—ABCB1—Topotecan—ovarian cancer	0.0286	0.267	CbGbCtD
Bepridil—ABCB1—Vinorelbine—ovarian cancer	0.0202	0.188	CbGbCtD
Bepridil—CYP2D6—Vinorelbine—ovarian cancer	0.019	0.178	CbGbCtD
Bepridil—ABCB1—Paclitaxel—ovarian cancer	0.0142	0.132	CbGbCtD
Bepridil—ABCB1—Docetaxel—ovarian cancer	0.0103	0.0957	CbGbCtD
Bepridil—ABCB1—Doxorubicin—ovarian cancer	0.00764	0.0714	CbGbCtD
Bepridil—CYP2D6—Doxorubicin—ovarian cancer	0.0072	0.0672	CbGbCtD
Bepridil—ATP1A1—oviduct—ovarian cancer	0.00587	0.0341	CbGeAlD
Bepridil—CALM2—oviduct—ovarian cancer	0.00517	0.0301	CbGeAlD
Bepridil—TNNC1—endometrium—ovarian cancer	0.0034	0.0198	CbGeAlD
Bepridil—CACNA1H—myometrium—ovarian cancer	0.0033	0.0192	CbGeAlD
Bepridil—PDE1B—gonad—ovarian cancer	0.00329	0.0192	CbGeAlD
Bepridil—PDE1A—uterine cervix—ovarian cancer	0.00329	0.0191	CbGeAlD
Bepridil—PDE1B—female reproductive system—ovarian cancer	0.00294	0.0171	CbGeAlD
Bepridil—KCNQ1—decidua—ovarian cancer	0.00291	0.0169	CbGeAlD
Bepridil—PDE1A—gonad—ovarian cancer	0.00276	0.016	CbGeAlD
Bepridil—PDE1A—uterus—ovarian cancer	0.00274	0.0159	CbGeAlD
Bepridil—CACNA1A—testis—ovarian cancer	0.00272	0.0158	CbGeAlD
Bepridil—CACNA1C—myometrium—ovarian cancer	0.00251	0.0146	CbGeAlD
Bepridil—PDE1A—female reproductive system—ovarian cancer	0.00246	0.0143	CbGeAlD
Bepridil—PDE1B—testis—ovarian cancer	0.00237	0.0138	CbGeAlD
Bepridil—KCNQ1—female reproductive system—ovarian cancer	0.00229	0.0133	CbGeAlD
Bepridil—TNNC1—testis—ovarian cancer	0.00227	0.0132	CbGeAlD
Bepridil—PDE1A—female gonad—ovarian cancer	0.00224	0.013	CbGeAlD
Bepridil—KCNQ1—bone marrow—ovarian cancer	0.00216	0.0126	CbGeAlD
Bepridil—CACNA1H—gonad—ovarian cancer	0.00215	0.0125	CbGeAlD
Bepridil—CACNA2D2—vagina—ovarian cancer	0.00214	0.0125	CbGeAlD
Bepridil—CACNA1H—uterus—ovarian cancer	0.00214	0.0124	CbGeAlD
Bepridil—CACNA1D—uterine cervix—ovarian cancer	0.00212	0.0123	CbGeAlD
Bepridil—CALM3—myometrium—ovarian cancer	0.0021	0.0122	CbGeAlD
Bepridil—KCNQ1—female gonad—ovarian cancer	0.00208	0.0121	CbGeAlD
Bepridil—PDE1A—testis—ovarian cancer	0.00199	0.0116	CbGeAlD
Bepridil—CACNA1H—female reproductive system—ovarian cancer	0.00192	0.0112	CbGeAlD
Bepridil—CACNA2D2—testis—ovarian cancer	0.00191	0.0111	CbGeAlD
Bepridil—ATP1A1—myometrium—ovarian cancer	0.00188	0.0109	CbGeAlD
Bepridil—CACNA1C—decidua—ovarian cancer	0.00186	0.0108	CbGeAlD
Bepridil—KCNQ1—testis—ovarian cancer	0.00185	0.0108	CbGeAlD
Bepridil—ATP1A1—embryo—ovarian cancer	0.00181	0.0105	CbGeAlD
Bepridil—CACNA1H—female gonad—ovarian cancer	0.00175	0.0102	CbGeAlD
Bepridil—PDE1B—lymph node—ovarian cancer	0.00172	0.01	CbGeAlD
Bepridil—CALM2—myometrium—ovarian cancer	0.00165	0.00962	CbGeAlD
Bepridil—TNNC1—lymph node—ovarian cancer	0.00165	0.00959	CbGeAlD
Bepridil—CALM1—myometrium—ovarian cancer	0.00165	0.00957	CbGeAlD
Bepridil—CALM3—uterine cervix—ovarian cancer	0.00164	0.00953	CbGeAlD
Bepridil—CALM2—embryo—ovarian cancer	0.00159	0.00925	CbGeAlD
Bepridil—CALM1—embryo—ovarian cancer	0.00158	0.00921	CbGeAlD
Bepridil—CALM3—decidua—ovarian cancer	0.00156	0.00908	CbGeAlD
Bepridil—CACNA1H—testis—ovarian cancer	0.00155	0.00903	CbGeAlD
Bepridil—KCNH2—myometrium—ovarian cancer	0.0015	0.00871	CbGeAlD
Bepridil—CALM3—endometrium—ovarian cancer	0.00148	0.00862	CbGeAlD
Bepridil—ATP1A1—epithelium—ovarian cancer	0.00147	0.00857	CbGeAlD
Bepridil—CACNA1C—female reproductive system—ovarian cancer	0.00147	0.00853	CbGeAlD
Bepridil—ATP1A1—uterine cervix—ovarian cancer	0.00146	0.0085	CbGeAlD
Bepridil—PDE1A—lymph node—ovarian cancer	0.00144	0.00839	CbGeAlD
Bepridil—ATP1A1—decidua—ovarian cancer	0.00139	0.0081	CbGeAlD
Bepridil—CACNA2D2—lymph node—ovarian cancer	0.00139	0.00807	CbGeAlD
Bepridil—CALM3—uterus—ovarian cancer	0.00137	0.00794	CbGeAlD
Bepridil—KCNQ1—lymph node—ovarian cancer	0.00134	0.0078	CbGeAlD
Bepridil—CACNA1C—vagina—ovarian cancer	0.00133	0.00771	CbGeAlD
Bepridil—ATP1A1—endometrium—ovarian cancer	0.00132	0.00769	CbGeAlD
Bepridil—CALM2—epithelium—ovarian cancer	0.0013	0.00755	CbGeAlD
Bepridil—CALM1—epithelium—ovarian cancer	0.00129	0.00751	CbGeAlD
Bepridil—CALM2—uterine cervix—ovarian cancer	0.00129	0.00749	CbGeAlD
Bepridil—CACNA1D—testis—ovarian cancer	0.00128	0.00745	CbGeAlD
Bepridil—CALM1—uterine cervix—ovarian cancer	0.00128	0.00745	CbGeAlD
Bepridil—CALM2—decidua—ovarian cancer	0.00123	0.00713	CbGeAlD
Bepridil—ATP1A1—gonad—ovarian cancer	0.00123	0.00713	CbGeAlD
Bepridil—CALM1—decidua—ovarian cancer	0.00122	0.0071	CbGeAlD
Bepridil—ATP1A1—uterus—ovarian cancer	0.00122	0.00708	CbGeAlD
Bepridil—CACNA1C—testis—ovarian cancer	0.00118	0.00688	CbGeAlD
Bepridil—KCNH2—uterine cervix—ovarian cancer	0.00117	0.00678	CbGeAlD
Bepridil—CALM2—endometrium—ovarian cancer	0.00116	0.00677	CbGeAlD
Bepridil—CALM3—bone marrow—ovarian cancer	0.00116	0.00674	CbGeAlD
Bepridil—CALM1—endometrium—ovarian cancer	0.00116	0.00674	CbGeAlD
Bepridil—CACNA1H—lymph node—ovarian cancer	0.00112	0.00655	CbGeAlD
Bepridil—CALM3—female gonad—ovarian cancer	0.00112	0.0065	CbGeAlD
Bepridil—CALM3—vagina—ovarian cancer	0.00111	0.00646	CbGeAlD
Bepridil—ATP1A1—female reproductive system—ovarian cancer	0.00109	0.00637	CbGeAlD
Bepridil—CALM2—gonad—ovarian cancer	0.00108	0.00628	CbGeAlD
Bepridil—CALM1—gonad—ovarian cancer	0.00107	0.00625	CbGeAlD
Bepridil—CALM2—uterus—ovarian cancer	0.00107	0.00624	CbGeAlD
Bepridil—CALM1—uterus—ovarian cancer	0.00107	0.00621	CbGeAlD
Bepridil—KCNH2—endometrium—ovarian cancer	0.00105	0.00613	CbGeAlD
Bepridil—ATP1A1—bone marrow—ovarian cancer	0.00103	0.00601	CbGeAlD
Bepridil—ATP1A1—female gonad—ovarian cancer	0.000996	0.00579	CbGeAlD
Bepridil—CALM3—testis—ovarian cancer	0.00099	0.00576	CbGeAlD
Bepridil—ATP1A1—vagina—ovarian cancer	0.00099	0.00576	CbGeAlD
Bepridil—KCNH2—uterus—ovarian cancer	0.000971	0.00565	CbGeAlD
Bepridil—CALM2—female reproductive system—ovarian cancer	0.000964	0.00561	CbGeAlD
Bepridil—CALM1—female reproductive system—ovarian cancer	0.000959	0.00558	CbGeAlD
Bepridil—CACNA1D—lymph node—ovarian cancer	0.000928	0.0054	CbGeAlD
Bepridil—CALM2—bone marrow—ovarian cancer	0.00091	0.00529	CbGeAlD
Bepridil—CALM1—bone marrow—ovarian cancer	0.000906	0.00527	CbGeAlD
Bepridil—ATP1A1—testis—ovarian cancer	0.000883	0.00514	CbGeAlD
Bepridil—CALM2—female gonad—ovarian cancer	0.000877	0.0051	CbGeAlD
Bepridil—KCNH2—female reproductive system—ovarian cancer	0.000873	0.00508	CbGeAlD
Bepridil—CALM1—female gonad—ovarian cancer	0.000873	0.00508	CbGeAlD
Bepridil—CALM2—vagina—ovarian cancer	0.000872	0.00507	CbGeAlD
Bepridil—CALM1—vagina—ovarian cancer	0.000868	0.00505	CbGeAlD
Bepridil—CACNA1C—lymph node—ovarian cancer	0.000857	0.00499	CbGeAlD
Bepridil—KCNH2—bone marrow—ovarian cancer	0.000824	0.0048	CbGeAlD
Bepridil—KCNH2—female gonad—ovarian cancer	0.000794	0.00462	CbGeAlD
Bepridil—KCNH2—vagina—ovarian cancer	0.000789	0.00459	CbGeAlD
Bepridil—CALM2—testis—ovarian cancer	0.000778	0.00453	CbGeAlD
Bepridil—CALM1—testis—ovarian cancer	0.000774	0.00451	CbGeAlD
Bepridil—CALM3—lymph node—ovarian cancer	0.000718	0.00418	CbGeAlD
Bepridil—KCNH2—testis—ovarian cancer	0.000704	0.0041	CbGeAlD
Bepridil—Vasodilation—Doxorubicin—ovarian cancer	0.00066	0.00461	CcSEcCtD
Bepridil—Gastrointestinal disorder—Chlorambucil—ovarian cancer	0.00066	0.0046	CcSEcCtD
Bepridil—Hyperhidrosis—Topotecan—ovarian cancer	0.000658	0.00459	CcSEcCtD
Bepridil—ABCB1—myometrium—ovarian cancer	0.000657	0.00382	CbGeAlD
Bepridil—Pain—Chlorambucil—ovarian cancer	0.000653	0.00456	CcSEcCtD
Bepridil—Anorexia—Topotecan—ovarian cancer	0.000648	0.00452	CcSEcCtD
Bepridil—Vertigo—Vinorelbine—ovarian cancer	0.000641	0.00447	CcSEcCtD
Bepridil—ATP1A1—lymph node—ovarian cancer	0.00064	0.00373	CbGeAlD
Bepridil—Anorexia—Melphalan—ovarian cancer	0.000635	0.00443	CcSEcCtD
Bepridil—ABCB1—embryo—ovarian cancer	0.000632	0.00368	CbGeAlD
Bepridil—Palpitations—Vinorelbine—ovarian cancer	0.00063	0.0044	CcSEcCtD
Bepridil—Ventricular tachycardia—Epirubicin—ovarian cancer	0.000627	0.00438	CcSEcCtD
Bepridil—Gastrointestinal pain—Chlorambucil—ovarian cancer	0.000625	0.00436	CcSEcCtD
Bepridil—Liver function test abnormal—Docetaxel—ovarian cancer	0.000623	0.00435	CcSEcCtD
Bepridil—Cough—Vinorelbine—ovarian cancer	0.000622	0.00434	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Topotecan—ovarian cancer	0.00062	0.00432	CcSEcCtD
Bepridil—Hypertension—Vinorelbine—ovarian cancer	0.000616	0.00429	CcSEcCtD
Bepridil—Depression—Paclitaxel—ovarian cancer	0.000612	0.00427	CcSEcCtD
Bepridil—Paraesthesia—Topotecan—ovarian cancer	0.000611	0.00426	CcSEcCtD
Bepridil—Myalgia—Vinorelbine—ovarian cancer	0.000607	0.00423	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Melphalan—ovarian cancer	0.000607	0.00423	CcSEcCtD
Bepridil—Dyspnoea—Topotecan—ovarian cancer	0.000606	0.00423	CcSEcCtD
Bepridil—Body temperature increased—Chlorambucil—ovarian cancer	0.000604	0.00421	CcSEcCtD
Bepridil—Abdominal pain—Chlorambucil—ovarian cancer	0.000604	0.00421	CcSEcCtD
Bepridil—Dyspepsia—Topotecan—ovarian cancer	0.000599	0.00418	CcSEcCtD
Bepridil—Paraesthesia—Melphalan—ovarian cancer	0.000598	0.00417	CcSEcCtD
Bepridil—Dyspnoea—Melphalan—ovarian cancer	0.000594	0.00414	CcSEcCtD
Bepridil—Decreased appetite—Topotecan—ovarian cancer	0.000591	0.00413	CcSEcCtD
Bepridil—Gastrointestinal disorder—Topotecan—ovarian cancer	0.000587	0.0041	CcSEcCtD
Bepridil—Dyspepsia—Melphalan—ovarian cancer	0.000586	0.00409	CcSEcCtD
Bepridil—Pain—Topotecan—ovarian cancer	0.000582	0.00406	CcSEcCtD
Bepridil—Constipation—Topotecan—ovarian cancer	0.000582	0.00406	CcSEcCtD
Bepridil—Ventricular tachycardia—Doxorubicin—ovarian cancer	0.00058	0.00405	CcSEcCtD
Bepridil—Decreased appetite—Melphalan—ovarian cancer	0.000579	0.00404	CcSEcCtD
Bepridil—Gastrointestinal disorder—Melphalan—ovarian cancer	0.000575	0.00401	CcSEcCtD
Bepridil—Pain—Melphalan—ovarian cancer	0.00057	0.00397	CcSEcCtD
Bepridil—Angina pectoris—Docetaxel—ovarian cancer	0.000568	0.00396	CcSEcCtD
Bepridil—CALM2—lymph node—ovarian cancer	0.000564	0.00328	CbGeAlD
Bepridil—CALM1—lymph node—ovarian cancer	0.000561	0.00327	CbGeAlD
Bepridil—Bradycardia—Paclitaxel—ovarian cancer	0.000561	0.00391	CcSEcCtD
Bepridil—Gastrointestinal pain—Topotecan—ovarian cancer	0.000556	0.00388	CcSEcCtD
Bepridil—Anorexia—Vinorelbine—ovarian cancer	0.000555	0.00387	CcSEcCtD
Bepridil—Rhinitis—Paclitaxel—ovarian cancer	0.000552	0.00385	CcSEcCtD
Bepridil—Asthenia—Chlorambucil—ovarian cancer	0.000548	0.00382	CcSEcCtD
Bepridil—Pharyngitis—Paclitaxel—ovarian cancer	0.000547	0.00381	CcSEcCtD
Bepridil—Abdominal pain—Topotecan—ovarian cancer	0.000538	0.00375	CcSEcCtD
Bepridil—Body temperature increased—Topotecan—ovarian cancer	0.000538	0.00375	CcSEcCtD
Bepridil—CYP2D6—female reproductive system—ovarian cancer	0.000532	0.0031	CbGeAlD
Bepridil—Musculoskeletal discomfort—Vinorelbine—ovarian cancer	0.00053	0.0037	CcSEcCtD
Bepridil—Diarrhoea—Chlorambucil—ovarian cancer	0.000523	0.00365	CcSEcCtD
Bepridil—Paraesthesia—Vinorelbine—ovarian cancer	0.000523	0.00365	CcSEcCtD
Bepridil—Dyspnoea—Vinorelbine—ovarian cancer	0.000519	0.00362	CcSEcCtD
Bepridil—ABCB1—epithelium—ovarian cancer	0.000515	0.003	CbGeAlD
Bepridil—Tinnitus—Paclitaxel—ovarian cancer	0.000514	0.00358	CcSEcCtD
Bepridil—Cardiac disorder—Paclitaxel—ovarian cancer	0.000511	0.00357	CcSEcCtD
Bepridil—ABCB1—uterine cervix—ovarian cancer	0.000511	0.00297	CbGeAlD
Bepridil—KCNH2—lymph node—ovarian cancer	0.000511	0.00297	CbGeAlD
Bepridil—Decreased appetite—Vinorelbine—ovarian cancer	0.000506	0.00353	CcSEcCtD
Bepridil—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.000502	0.0035	CcSEcCtD
Bepridil—Pain—Vinorelbine—ovarian cancer	0.000498	0.00347	CcSEcCtD
Bepridil—Constipation—Vinorelbine—ovarian cancer	0.000498	0.00347	CcSEcCtD
Bepridil—Arrhythmia—Paclitaxel—ovarian cancer	0.000492	0.00343	CcSEcCtD
Bepridil—Asthenia—Topotecan—ovarian cancer	0.000488	0.0034	CcSEcCtD
Bepridil—ABCB1—decidua—ovarian cancer	0.000487	0.00283	CbGeAlD
Bepridil—Increased appetite—Epirubicin—ovarian cancer	0.000485	0.00338	CcSEcCtD
Bepridil—CYP2D6—female gonad—ovarian cancer	0.000484	0.00282	CbGeAlD
Bepridil—Asthenia—Melphalan—ovarian cancer	0.000478	0.00333	CcSEcCtD
Bepridil—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.000476	0.00332	CcSEcCtD
Bepridil—Flatulence—Paclitaxel—ovarian cancer	0.000473	0.0033	CcSEcCtD
Bepridil—Tension—Paclitaxel—ovarian cancer	0.000471	0.00328	CcSEcCtD
Bepridil—Rhinitis—Docetaxel—ovarian cancer	0.000468	0.00327	CcSEcCtD
Bepridil—Cardiac failure—Epirubicin—ovarian cancer	0.000467	0.00325	CcSEcCtD
Bepridil—Nervousness—Paclitaxel—ovarian cancer	0.000466	0.00325	CcSEcCtD
Bepridil—Diarrhoea—Topotecan—ovarian cancer	0.000465	0.00325	CcSEcCtD
Bepridil—Pharyngitis—Docetaxel—ovarian cancer	0.000463	0.00323	CcSEcCtD
Bepridil—ABCB1—endometrium—ovarian cancer	0.000462	0.00269	CbGeAlD
Bepridil—Body temperature increased—Vinorelbine—ovarian cancer	0.00046	0.00321	CcSEcCtD
Bepridil—Abdominal pain—Vinorelbine—ovarian cancer	0.00046	0.00321	CcSEcCtD
Bepridil—Diarrhoea—Melphalan—ovarian cancer	0.000456	0.00318	CcSEcCtD
Bepridil—Nausea—Chlorambucil—ovarian cancer	0.000454	0.00317	CcSEcCtD
Bepridil—Vision blurred—Paclitaxel—ovarian cancer	0.000452	0.00315	CcSEcCtD
Bepridil—Dizziness—Topotecan—ovarian cancer	0.00045	0.00314	CcSEcCtD
Bepridil—Tremor—Paclitaxel—ovarian cancer	0.000449	0.00313	CcSEcCtD
Bepridil—Increased appetite—Doxorubicin—ovarian cancer	0.000448	0.00313	CcSEcCtD
Bepridil—Cardiac disorder—Docetaxel—ovarian cancer	0.000433	0.00302	CcSEcCtD
Bepridil—Cardiac failure—Doxorubicin—ovarian cancer	0.000432	0.00301	CcSEcCtD
Bepridil—Vertigo—Paclitaxel—ovarian cancer	0.000431	0.00301	CcSEcCtD
Bepridil—Syncope—Paclitaxel—ovarian cancer	0.00043	0.003	CcSEcCtD
Bepridil—CYP2D6—testis—ovarian cancer	0.00043	0.0025	CbGeAlD
Bepridil—Rash—Topotecan—ovarian cancer	0.000429	0.00299	CcSEcCtD
Bepridil—ABCB1—gonad—ovarian cancer	0.000429	0.0025	CbGeAlD
Bepridil—Dermatitis—Topotecan—ovarian cancer	0.000429	0.00299	CcSEcCtD
Bepridil—Headache—Topotecan—ovarian cancer	0.000426	0.00297	CcSEcCtD
Bepridil—ABCB1—uterus—ovarian cancer	0.000426	0.00248	CbGeAlD
Bepridil—Palpitations—Paclitaxel—ovarian cancer	0.000424	0.00296	CcSEcCtD
Bepridil—Loss of consciousness—Paclitaxel—ovarian cancer	0.000422	0.00294	CcSEcCtD
Bepridil—Liver function test abnormal—Epirubicin—ovarian cancer	0.00042	0.00293	CcSEcCtD
Bepridil—Rash—Melphalan—ovarian cancer	0.00042	0.00293	CcSEcCtD
Bepridil—Dermatitis—Melphalan—ovarian cancer	0.00042	0.00293	CcSEcCtD
Bepridil—Cough—Paclitaxel—ovarian cancer	0.000419	0.00292	CcSEcCtD
Bepridil—Asthenia—Vinorelbine—ovarian cancer	0.000418	0.00291	CcSEcCtD
Bepridil—Arrhythmia—Docetaxel—ovarian cancer	0.000417	0.00291	CcSEcCtD
Bepridil—Hypertension—Paclitaxel—ovarian cancer	0.000414	0.00289	CcSEcCtD
Bepridil—Myalgia—Paclitaxel—ovarian cancer	0.000408	0.00285	CcSEcCtD
Bepridil—Anxiety—Paclitaxel—ovarian cancer	0.000407	0.00284	CcSEcCtD
Bepridil—Nausea—Topotecan—ovarian cancer	0.000404	0.00282	CcSEcCtD
Bepridil—Gastritis—Epirubicin—ovarian cancer	0.000403	0.00281	CcSEcCtD
Bepridil—Dry mouth—Paclitaxel—ovarian cancer	0.000399	0.00279	CcSEcCtD
Bepridil—Diarrhoea—Vinorelbine—ovarian cancer	0.000398	0.00278	CcSEcCtD
Bepridil—Nausea—Melphalan—ovarian cancer	0.000396	0.00276	CcSEcCtD
Bepridil—Influenza—Epirubicin—ovarian cancer	0.000394	0.00275	CcSEcCtD
Bepridil—Oedema—Paclitaxel—ovarian cancer	0.000391	0.00273	CcSEcCtD
Bepridil—Liver function test abnormal—Doxorubicin—ovarian cancer	0.000389	0.00271	CcSEcCtD
Bepridil—Shock—Paclitaxel—ovarian cancer	0.000385	0.00269	CcSEcCtD
Bepridil—Dizziness—Vinorelbine—ovarian cancer	0.000385	0.00268	CcSEcCtD
Bepridil—Angina pectoris—Epirubicin—ovarian cancer	0.000383	0.00267	CcSEcCtD
Bepridil—ABCB1—female reproductive system—ovarian cancer	0.000383	0.00223	CbGeAlD
Bepridil—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000378	0.00264	CcSEcCtD
Bepridil—Anorexia—Paclitaxel—ovarian cancer	0.000373	0.0026	CcSEcCtD
Bepridil—Gastritis—Doxorubicin—ovarian cancer	0.000373	0.0026	CcSEcCtD
Bepridil—Rash—Vinorelbine—ovarian cancer	0.000367	0.00256	CcSEcCtD
Bepridil—Dermatitis—Vinorelbine—ovarian cancer	0.000367	0.00256	CcSEcCtD
Bepridil—Headache—Vinorelbine—ovarian cancer	0.000365	0.00254	CcSEcCtD
Bepridil—Syncope—Docetaxel—ovarian cancer	0.000365	0.00254	CcSEcCtD
Bepridil—Influenza—Doxorubicin—ovarian cancer	0.000364	0.00254	CcSEcCtD
Bepridil—ABCB1—bone marrow—ovarian cancer	0.000362	0.0021	CbGeAlD
Bepridil—Palpitations—Docetaxel—ovarian cancer	0.000359	0.00251	CcSEcCtD
Bepridil—Loss of consciousness—Docetaxel—ovarian cancer	0.000357	0.00249	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000357	0.00249	CcSEcCtD
Bepridil—Cough—Docetaxel—ovarian cancer	0.000355	0.00247	CcSEcCtD
Bepridil—Angina pectoris—Doxorubicin—ovarian cancer	0.000355	0.00247	CcSEcCtD
Bepridil—Insomnia—Paclitaxel—ovarian cancer	0.000354	0.00247	CcSEcCtD
Bepridil—Paraesthesia—Paclitaxel—ovarian cancer	0.000351	0.00245	CcSEcCtD
Bepridil—Hypertension—Docetaxel—ovarian cancer	0.000351	0.00245	CcSEcCtD
Bepridil—Drowsiness—Epirubicin—ovarian cancer	0.000351	0.00245	CcSEcCtD
Bepridil—Dyspnoea—Paclitaxel—ovarian cancer	0.000349	0.00243	CcSEcCtD
Bepridil—ABCB1—female gonad—ovarian cancer	0.000348	0.00203	CbGeAlD
Bepridil—Somnolence—Paclitaxel—ovarian cancer	0.000348	0.00243	CcSEcCtD
Bepridil—ABCB1—vagina—ovarian cancer	0.000346	0.00202	CbGeAlD
Bepridil—Myalgia—Docetaxel—ovarian cancer	0.000346	0.00241	CcSEcCtD
Bepridil—Nausea—Vinorelbine—ovarian cancer	0.000346	0.00241	CcSEcCtD
Bepridil—Dyspepsia—Paclitaxel—ovarian cancer	0.000345	0.0024	CcSEcCtD
Bepridil—Decreased appetite—Paclitaxel—ovarian cancer	0.00034	0.00237	CcSEcCtD
Bepridil—Dry mouth—Docetaxel—ovarian cancer	0.000338	0.00236	CcSEcCtD
Bepridil—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000338	0.00236	CcSEcCtD
Bepridil—Sweating—Epirubicin—ovarian cancer	0.000336	0.00235	CcSEcCtD
Bepridil—Pain—Paclitaxel—ovarian cancer	0.000335	0.00233	CcSEcCtD
Bepridil—Constipation—Paclitaxel—ovarian cancer	0.000335	0.00233	CcSEcCtD
Bepridil—Oedema—Docetaxel—ovarian cancer	0.000332	0.00231	CcSEcCtD
Bepridil—Shock—Docetaxel—ovarian cancer	0.000326	0.00228	CcSEcCtD
Bepridil—Drowsiness—Doxorubicin—ovarian cancer	0.000325	0.00226	CcSEcCtD
Bepridil—Bradycardia—Epirubicin—ovarian cancer	0.000321	0.00224	CcSEcCtD
Bepridil—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.00032	0.00223	CcSEcCtD
Bepridil—Anorexia—Docetaxel—ovarian cancer	0.000316	0.00221	CcSEcCtD
Bepridil—Rhinitis—Epirubicin—ovarian cancer	0.000316	0.0022	CcSEcCtD
Bepridil—Pharyngitis—Epirubicin—ovarian cancer	0.000313	0.00218	CcSEcCtD
Bepridil—Sweating—Doxorubicin—ovarian cancer	0.000311	0.00217	CcSEcCtD
Bepridil—Body temperature increased—Paclitaxel—ovarian cancer	0.000309	0.00216	CcSEcCtD
Bepridil—Abdominal pain—Paclitaxel—ovarian cancer	0.000309	0.00216	CcSEcCtD
Bepridil—ABCB1—testis—ovarian cancer	0.000309	0.0018	CbGeAlD
Bepridil—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000302	0.00211	CcSEcCtD
Bepridil—Insomnia—Docetaxel—ovarian cancer	0.0003	0.00209	CcSEcCtD
Bepridil—Paraesthesia—Docetaxel—ovarian cancer	0.000298	0.00208	CcSEcCtD
Bepridil—Bradycardia—Doxorubicin—ovarian cancer	0.000297	0.00207	CcSEcCtD
Bepridil—Dyspnoea—Docetaxel—ovarian cancer	0.000296	0.00206	CcSEcCtD
Bepridil—Somnolence—Docetaxel—ovarian cancer	0.000295	0.00206	CcSEcCtD
Bepridil—Tinnitus—Epirubicin—ovarian cancer	0.000294	0.00205	CcSEcCtD
Bepridil—Cardiac disorder—Epirubicin—ovarian cancer	0.000292	0.00204	CcSEcCtD
Bepridil—Rhinitis—Doxorubicin—ovarian cancer	0.000292	0.00204	CcSEcCtD
Bepridil—Dyspepsia—Docetaxel—ovarian cancer	0.000292	0.00204	CcSEcCtD
Bepridil—Pharyngitis—Doxorubicin—ovarian cancer	0.000289	0.00202	CcSEcCtD
Bepridil—Decreased appetite—Docetaxel—ovarian cancer	0.000288	0.00201	CcSEcCtD
Bepridil—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000286	0.002	CcSEcCtD
Bepridil—Pain—Docetaxel—ovarian cancer	0.000284	0.00198	CcSEcCtD
Bepridil—Constipation—Docetaxel—ovarian cancer	0.000284	0.00198	CcSEcCtD
Bepridil—Arrhythmia—Epirubicin—ovarian cancer	0.000281	0.00196	CcSEcCtD
Bepridil—Asthenia—Paclitaxel—ovarian cancer	0.000281	0.00196	CcSEcCtD
Bepridil—Tinnitus—Doxorubicin—ovarian cancer	0.000272	0.0019	CcSEcCtD
Bepridil—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000271	0.00189	CcSEcCtD
Bepridil—Cardiac disorder—Doxorubicin—ovarian cancer	0.00027	0.00189	CcSEcCtD
Bepridil—Flatulence—Epirubicin—ovarian cancer	0.00027	0.00188	CcSEcCtD
Bepridil—Tension—Epirubicin—ovarian cancer	0.000269	0.00188	CcSEcCtD
Bepridil—Diarrhoea—Paclitaxel—ovarian cancer	0.000268	0.00187	CcSEcCtD
Bepridil—Nervousness—Epirubicin—ovarian cancer	0.000266	0.00186	CcSEcCtD
Bepridil—Abdominal pain—Docetaxel—ovarian cancer	0.000262	0.00183	CcSEcCtD
Bepridil—Body temperature increased—Docetaxel—ovarian cancer	0.000262	0.00183	CcSEcCtD
Bepridil—Arrhythmia—Doxorubicin—ovarian cancer	0.00026	0.00182	CcSEcCtD
Bepridil—Dizziness—Paclitaxel—ovarian cancer	0.000259	0.00181	CcSEcCtD
Bepridil—Vision blurred—Epirubicin—ovarian cancer	0.000258	0.0018	CcSEcCtD
Bepridil—Flatulence—Doxorubicin—ovarian cancer	0.00025	0.00174	CcSEcCtD
Bepridil—Tension—Doxorubicin—ovarian cancer	0.000249	0.00174	CcSEcCtD
Bepridil—Rash—Paclitaxel—ovarian cancer	0.000247	0.00172	CcSEcCtD
Bepridil—Dermatitis—Paclitaxel—ovarian cancer	0.000247	0.00172	CcSEcCtD
Bepridil—Nervousness—Doxorubicin—ovarian cancer	0.000246	0.00172	CcSEcCtD
Bepridil—Vertigo—Epirubicin—ovarian cancer	0.000246	0.00172	CcSEcCtD
Bepridil—Syncope—Epirubicin—ovarian cancer	0.000246	0.00172	CcSEcCtD
Bepridil—Headache—Paclitaxel—ovarian cancer	0.000245	0.00171	CcSEcCtD
Bepridil—Palpitations—Epirubicin—ovarian cancer	0.000242	0.00169	CcSEcCtD
Bepridil—Loss of consciousness—Epirubicin—ovarian cancer	0.000241	0.00168	CcSEcCtD
Bepridil—Cough—Epirubicin—ovarian cancer	0.000239	0.00167	CcSEcCtD
Bepridil—Vision blurred—Doxorubicin—ovarian cancer	0.000239	0.00167	CcSEcCtD
Bepridil—Asthenia—Docetaxel—ovarian cancer	0.000238	0.00166	CcSEcCtD
Bepridil—Hypertension—Epirubicin—ovarian cancer	0.000237	0.00165	CcSEcCtD
Bepridil—Myalgia—Epirubicin—ovarian cancer	0.000233	0.00163	CcSEcCtD
Bepridil—Anxiety—Epirubicin—ovarian cancer	0.000233	0.00162	CcSEcCtD
Bepridil—Nausea—Paclitaxel—ovarian cancer	0.000232	0.00162	CcSEcCtD
Bepridil—Dry mouth—Epirubicin—ovarian cancer	0.000228	0.00159	CcSEcCtD
Bepridil—Vertigo—Doxorubicin—ovarian cancer	0.000228	0.00159	CcSEcCtD
Bepridil—Syncope—Doxorubicin—ovarian cancer	0.000228	0.00159	CcSEcCtD
Bepridil—Diarrhoea—Docetaxel—ovarian cancer	0.000227	0.00158	CcSEcCtD
Bepridil—Palpitations—Doxorubicin—ovarian cancer	0.000224	0.00156	CcSEcCtD
Bepridil—ABCB1—lymph node—ovarian cancer	0.000224	0.0013	CbGeAlD
Bepridil—Oedema—Epirubicin—ovarian cancer	0.000224	0.00156	CcSEcCtD
Bepridil—Loss of consciousness—Doxorubicin—ovarian cancer	0.000223	0.00156	CcSEcCtD
Bepridil—Cough—Doxorubicin—ovarian cancer	0.000221	0.00154	CcSEcCtD
Bepridil—Shock—Epirubicin—ovarian cancer	0.00022	0.00154	CcSEcCtD
Bepridil—Dizziness—Docetaxel—ovarian cancer	0.000219	0.00153	CcSEcCtD
Bepridil—Hypertension—Doxorubicin—ovarian cancer	0.000219	0.00153	CcSEcCtD
Bepridil—Hyperhidrosis—Epirubicin—ovarian cancer	0.000216	0.00151	CcSEcCtD
Bepridil—Myalgia—Doxorubicin—ovarian cancer	0.000216	0.00151	CcSEcCtD
Bepridil—Anxiety—Doxorubicin—ovarian cancer	0.000215	0.0015	CcSEcCtD
Bepridil—Anorexia—Epirubicin—ovarian cancer	0.000213	0.00149	CcSEcCtD
Bepridil—Dry mouth—Doxorubicin—ovarian cancer	0.000211	0.00147	CcSEcCtD
Bepridil—Rash—Docetaxel—ovarian cancer	0.000209	0.00146	CcSEcCtD
Bepridil—Dermatitis—Docetaxel—ovarian cancer	0.000209	0.00146	CcSEcCtD
Bepridil—Headache—Docetaxel—ovarian cancer	0.000208	0.00145	CcSEcCtD
Bepridil—Oedema—Doxorubicin—ovarian cancer	0.000207	0.00144	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000204	0.00142	CcSEcCtD
Bepridil—Shock—Doxorubicin—ovarian cancer	0.000204	0.00142	CcSEcCtD
Bepridil—Insomnia—Epirubicin—ovarian cancer	0.000202	0.00141	CcSEcCtD
Bepridil—Paraesthesia—Epirubicin—ovarian cancer	0.000201	0.0014	CcSEcCtD
Bepridil—Hyperhidrosis—Doxorubicin—ovarian cancer	0.0002	0.0014	CcSEcCtD
Bepridil—Dyspnoea—Epirubicin—ovarian cancer	0.0002	0.00139	CcSEcCtD
Bepridil—Somnolence—Epirubicin—ovarian cancer	0.000199	0.00139	CcSEcCtD
Bepridil—Anorexia—Doxorubicin—ovarian cancer	0.000197	0.00138	CcSEcCtD
Bepridil—Nausea—Docetaxel—ovarian cancer	0.000197	0.00137	CcSEcCtD
Bepridil—Dyspepsia—Epirubicin—ovarian cancer	0.000197	0.00137	CcSEcCtD
Bepridil—Decreased appetite—Epirubicin—ovarian cancer	0.000195	0.00136	CcSEcCtD
Bepridil—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000193	0.00135	CcSEcCtD
Bepridil—Pain—Epirubicin—ovarian cancer	0.000191	0.00133	CcSEcCtD
Bepridil—Constipation—Epirubicin—ovarian cancer	0.000191	0.00133	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000189	0.00132	CcSEcCtD
Bepridil—Insomnia—Doxorubicin—ovarian cancer	0.000187	0.00131	CcSEcCtD
Bepridil—Paraesthesia—Doxorubicin—ovarian cancer	0.000186	0.0013	CcSEcCtD
Bepridil—Dyspnoea—Doxorubicin—ovarian cancer	0.000185	0.00129	CcSEcCtD
Bepridil—Somnolence—Doxorubicin—ovarian cancer	0.000184	0.00128	CcSEcCtD
Bepridil—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000183	0.00128	CcSEcCtD
Bepridil—Dyspepsia—Doxorubicin—ovarian cancer	0.000182	0.00127	CcSEcCtD
Bepridil—Decreased appetite—Doxorubicin—ovarian cancer	0.00018	0.00126	CcSEcCtD
Bepridil—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000179	0.00125	CcSEcCtD
Bepridil—Constipation—Doxorubicin—ovarian cancer	0.000177	0.00124	CcSEcCtD
Bepridil—Pain—Doxorubicin—ovarian cancer	0.000177	0.00124	CcSEcCtD
Bepridil—Abdominal pain—Epirubicin—ovarian cancer	0.000177	0.00123	CcSEcCtD
Bepridil—Body temperature increased—Epirubicin—ovarian cancer	0.000177	0.00123	CcSEcCtD
Bepridil—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000169	0.00118	CcSEcCtD
Bepridil—Abdominal pain—Doxorubicin—ovarian cancer	0.000164	0.00114	CcSEcCtD
Bepridil—Body temperature increased—Doxorubicin—ovarian cancer	0.000164	0.00114	CcSEcCtD
Bepridil—Asthenia—Epirubicin—ovarian cancer	0.000161	0.00112	CcSEcCtD
Bepridil—Diarrhoea—Epirubicin—ovarian cancer	0.000153	0.00107	CcSEcCtD
Bepridil—Asthenia—Doxorubicin—ovarian cancer	0.000149	0.00104	CcSEcCtD
Bepridil—Dizziness—Epirubicin—ovarian cancer	0.000148	0.00103	CcSEcCtD
Bepridil—Diarrhoea—Doxorubicin—ovarian cancer	0.000142	0.000988	CcSEcCtD
Bepridil—Rash—Epirubicin—ovarian cancer	0.000141	0.000984	CcSEcCtD
Bepridil—Dermatitis—Epirubicin—ovarian cancer	0.000141	0.000983	CcSEcCtD
Bepridil—Headache—Epirubicin—ovarian cancer	0.00014	0.000978	CcSEcCtD
Bepridil—Dizziness—Doxorubicin—ovarian cancer	0.000137	0.000955	CcSEcCtD
Bepridil—Nausea—Epirubicin—ovarian cancer	0.000133	0.000927	CcSEcCtD
Bepridil—Rash—Doxorubicin—ovarian cancer	0.000131	0.000911	CcSEcCtD
Bepridil—Dermatitis—Doxorubicin—ovarian cancer	0.00013	0.00091	CcSEcCtD
Bepridil—Headache—Doxorubicin—ovarian cancer	0.00013	0.000905	CcSEcCtD
Bepridil—Nausea—Doxorubicin—ovarian cancer	0.000123	0.000858	CcSEcCtD
Bepridil—CALM2—Hemostasis—AKT1—ovarian cancer	9.2e-06	3.79e-05	CbGpPWpGaD
Bepridil—CALM1—Hemostasis—AKT1—ovarian cancer	9.2e-06	3.79e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—IL2—ovarian cancer	9.2e-06	3.79e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—CDKN1B—ovarian cancer	9.09e-06	3.75e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—CDKN1B—ovarian cancer	9.09e-06	3.75e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—ERBB2—ovarian cancer	9.07e-06	3.74e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—ERBB2—ovarian cancer	9.07e-06	3.74e-05	CbGpPWpGaD
Bepridil—CALM2—Adaptive Immune System—HRAS—ovarian cancer	9.01e-06	3.72e-05	CbGpPWpGaD
Bepridil—CALM1—Adaptive Immune System—HRAS—ovarian cancer	9.01e-06	3.72e-05	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—IL6—ovarian cancer	8.98e-06	3.7e-05	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—IL6—ovarian cancer	8.98e-06	3.7e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—CAV1—ovarian cancer	8.98e-06	3.7e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—CAV1—ovarian cancer	8.98e-06	3.7e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—PIK3CB—ovarian cancer	8.95e-06	3.69e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—MTOR—ovarian cancer	8.95e-06	3.69e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—PIK3CB—ovarian cancer	8.95e-06	3.69e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—MTOR—ovarian cancer	8.95e-06	3.69e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—ESR1—ovarian cancer	8.94e-06	3.69e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—IL2—ovarian cancer	8.9e-06	3.67e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—IL2—ovarian cancer	8.9e-06	3.67e-05	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—AKT1—ovarian cancer	8.9e-06	3.67e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—PIK3CD—ovarian cancer	8.89e-06	3.66e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—CTNNB1—ovarian cancer	8.88e-06	3.66e-05	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—IL6—ovarian cancer	8.82e-06	3.64e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—IL6ST—ovarian cancer	8.8e-06	3.63e-05	CbGpPWpGaD
Bepridil—CACNA1C—Metabolism—AKT1—ovarian cancer	8.75e-06	3.61e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—CDKN1B—ovarian cancer	8.68e-06	3.58e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—PTEN—ovarian cancer	8.66e-06	3.57e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—ESR1—ovarian cancer	8.65e-06	3.57e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—ESR1—ovarian cancer	8.65e-06	3.57e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—PIK3CD—ovarian cancer	8.6e-06	3.54e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—PIK3CD—ovarian cancer	8.6e-06	3.54e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—CTNNB1—ovarian cancer	8.59e-06	3.54e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—CTNNB1—ovarian cancer	8.59e-06	3.54e-05	CbGpPWpGaD
Bepridil—CALM3—Innate Immune System—AKT1—ovarian cancer	8.57e-06	3.53e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—IL6ST—ovarian cancer	8.51e-06	3.51e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—IL6ST—ovarian cancer	8.51e-06	3.51e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—APC—ovarian cancer	8.45e-06	3.49e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—PIK3CG—ovarian cancer	8.45e-06	3.49e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—NRAS—ovarian cancer	8.45e-06	3.49e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—CAV1—ovarian cancer	8.41e-06	3.47e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—CDKN1B—ovarian cancer	8.4e-06	3.46e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—CDKN1B—ovarian cancer	8.4e-06	3.46e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—PTEN—ovarian cancer	8.37e-06	3.45e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—PTEN—ovarian cancer	8.37e-06	3.45e-05	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—AKT1—ovarian cancer	8.29e-06	3.42e-05	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—AKT1—ovarian cancer	8.29e-06	3.42e-05	CbGpPWpGaD
Bepridil—CALM3—Adaptive Immune System—AKT1—ovarian cancer	8.23e-06	3.39e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—CTNNB1—ovarian cancer	8.2e-06	3.38e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—PIK3CG—ovarian cancer	8.18e-06	3.37e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—PIK3CG—ovarian cancer	8.18e-06	3.37e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—APC—ovarian cancer	8.18e-06	3.37e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—APC—ovarian cancer	8.18e-06	3.37e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—NRAS—ovarian cancer	8.18e-06	3.37e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—NRAS—ovarian cancer	8.18e-06	3.37e-05	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—AKT1—ovarian cancer	8.14e-06	3.35e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—MAPK3—ovarian cancer	8.1e-06	3.34e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—PTEN—ovarian cancer	7.99e-06	3.3e-05	CbGpPWpGaD
Bepridil—CALM1—Adaptive Immune System—AKT1—ovarian cancer	7.96e-06	3.28e-05	CbGpPWpGaD
Bepridil—CALM2—Adaptive Immune System—AKT1—ovarian cancer	7.96e-06	3.28e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—CTNNB1—ovarian cancer	7.93e-06	3.27e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—CTNNB1—ovarian cancer	7.93e-06	3.27e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—CAV1—ovarian cancer	7.93e-06	3.27e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—MAPK3—ovarian cancer	7.83e-06	3.23e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—MAPK3—ovarian cancer	7.83e-06	3.23e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—PIK3CB—ovarian cancer	7.75e-06	3.19e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—STAT3—ovarian cancer	7.74e-06	3.19e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—PTEN—ovarian cancer	7.73e-06	3.19e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—PTEN—ovarian cancer	7.73e-06	3.19e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—NRAS—ovarian cancer	7.72e-06	3.18e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—MAPK1—ovarian cancer	7.7e-06	3.18e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—EGFR—ovarian cancer	7.7e-06	3.18e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—PIK3CG—ovarian cancer	7.66e-06	3.16e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—PIK3CB—ovarian cancer	7.49e-06	3.09e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—PIK3CB—ovarian cancer	7.49e-06	3.09e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—STAT3—ovarian cancer	7.49e-06	3.09e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—STAT3—ovarian cancer	7.49e-06	3.09e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—NRAS—ovarian cancer	7.47e-06	3.08e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—NRAS—ovarian cancer	7.47e-06	3.08e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—MAPK1—ovarian cancer	7.45e-06	3.07e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—MAPK1—ovarian cancer	7.45e-06	3.07e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—EGFR—ovarian cancer	7.45e-06	3.07e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—EGFR—ovarian cancer	7.45e-06	3.07e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—PIK3CD—ovarian cancer	7.43e-06	3.06e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—MAPK3—ovarian cancer	7.4e-06	3.05e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—KRAS—ovarian cancer	7.28e-06	3e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—PIK3CG—ovarian cancer	7.22e-06	2.98e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—PIK3CD—ovarian cancer	7.19e-06	2.96e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—PIK3CD—ovarian cancer	7.19e-06	2.96e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—MAPK3—ovarian cancer	7.16e-06	2.95e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—MAPK3—ovarian cancer	7.16e-06	2.95e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—STAT3—ovarian cancer	7.15e-06	2.95e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—NRAS—ovarian cancer	7.13e-06	2.94e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—MAPK1—ovarian cancer	7.04e-06	2.9e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—KRAS—ovarian cancer	7.04e-06	2.9e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—KRAS—ovarian cancer	7.04e-06	2.9e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—EGFR—ovarian cancer	7.04e-06	2.9e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—STAT3—ovarian cancer	6.91e-06	2.85e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—STAT3—ovarian cancer	6.91e-06	2.85e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—NRAS—ovarian cancer	6.9e-06	2.84e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—NRAS—ovarian cancer	6.9e-06	2.84e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—MAPK3—ovarian cancer	6.83e-06	2.82e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—MAPK1—ovarian cancer	6.81e-06	2.81e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—MAPK1—ovarian cancer	6.81e-06	2.81e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—EGFR—ovarian cancer	6.81e-06	2.81e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—EGFR—ovarian cancer	6.81e-06	2.81e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—PIK3CD—ovarian cancer	6.74e-06	2.78e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—PTEN—ovarian cancer	6.69e-06	2.76e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—PIK3CA—ovarian cancer	6.68e-06	2.76e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—KRAS—ovarian cancer	6.65e-06	2.74e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—MYC—ovarian cancer	6.64e-06	2.74e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—MAPK3—ovarian cancer	6.61e-06	2.72e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—MAPK3—ovarian cancer	6.61e-06	2.72e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—ERBB2—ovarian cancer	6.56e-06	2.71e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—MAPK1—ovarian cancer	6.5e-06	2.68e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—EGFR—ovarian cancer	6.5e-06	2.68e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—MTOR—ovarian cancer	6.48e-06	2.67e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—PIK3CB—ovarian cancer	6.48e-06	2.67e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—PTEN—ovarian cancer	6.48e-06	2.67e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—PTEN—ovarian cancer	6.48e-06	2.67e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—PIK3CA—ovarian cancer	6.47e-06	2.67e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—PIK3CA—ovarian cancer	6.47e-06	2.67e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—KRAS—ovarian cancer	6.43e-06	2.65e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—KRAS—ovarian cancer	6.43e-06	2.65e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—MYC—ovarian cancer	6.43e-06	2.65e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—MYC—ovarian cancer	6.43e-06	2.65e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—ERBB2—ovarian cancer	6.35e-06	2.62e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—ERBB2—ovarian cancer	6.35e-06	2.62e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—PIK3CD—ovarian cancer	6.35e-06	2.62e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—MAPK1—ovarian cancer	6.29e-06	2.59e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—MAPK1—ovarian cancer	6.29e-06	2.59e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—EGFR—ovarian cancer	6.28e-06	2.59e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—EGFR—ovarian cancer	6.28e-06	2.59e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—MTOR—ovarian cancer	6.27e-06	2.58e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—MTOR—ovarian cancer	6.27e-06	2.58e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—PIK3CB—ovarian cancer	6.27e-06	2.58e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—PIK3CB—ovarian cancer	6.27e-06	2.58e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—CXCL8—ovarian cancer	6.22e-06	2.57e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—HRAS—ovarian cancer	6.18e-06	2.55e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—KRAS—ovarian cancer	6.14e-06	2.53e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—PIK3CA—ovarian cancer	6.11e-06	2.52e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—CDKN1B—ovarian cancer	6.08e-06	2.51e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—CXCL8—ovarian cancer	6.02e-06	2.48e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—CXCL8—ovarian cancer	6.02e-06	2.48e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—HRAS—ovarian cancer	5.98e-06	2.47e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—HRAS—ovarian cancer	5.98e-06	2.47e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—CASP3—ovarian cancer	5.96e-06	2.46e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—IL2—ovarian cancer	5.95e-06	2.45e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—KRAS—ovarian cancer	5.94e-06	2.45e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—KRAS—ovarian cancer	5.94e-06	2.45e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—IL6—ovarian cancer	5.92e-06	2.44e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—PIK3CA—ovarian cancer	5.91e-06	2.44e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—PIK3CA—ovarian cancer	5.91e-06	2.44e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—CDKN1B—ovarian cancer	5.88e-06	2.42e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—CDKN1B—ovarian cancer	5.88e-06	2.42e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—PIK3CB—ovarian cancer	5.87e-06	2.42e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—CCND1—ovarian cancer	5.8e-06	2.39e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—CASP3—ovarian cancer	5.76e-06	2.38e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—CASP3—ovarian cancer	5.76e-06	2.38e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—IL2—ovarian cancer	5.75e-06	2.37e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—IL2—ovarian cancer	5.75e-06	2.37e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—CTNNB1—ovarian cancer	5.74e-06	2.37e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—IL6—ovarian cancer	5.73e-06	2.36e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—IL6—ovarian cancer	5.73e-06	2.36e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—HRAS—ovarian cancer	5.65e-06	2.33e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—PIK3CA—ovarian cancer	5.64e-06	2.32e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—MMP9—ovarian cancer	5.63e-06	2.32e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—CCND1—ovarian cancer	5.61e-06	2.31e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—CCND1—ovarian cancer	5.61e-06	2.31e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—PTEN—ovarian cancer	5.6e-06	2.31e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—CTNNB1—ovarian cancer	5.55e-06	2.29e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—CTNNB1—ovarian cancer	5.55e-06	2.29e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—PIK3CB—ovarian cancer	5.53e-06	2.28e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—HRAS—ovarian cancer	5.47e-06	2.25e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—HRAS—ovarian cancer	5.47e-06	2.25e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—AKT1—ovarian cancer	5.46e-06	2.25e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—PIK3CA—ovarian cancer	5.45e-06	2.25e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—PIK3CA—ovarian cancer	5.45e-06	2.25e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—MMP9—ovarian cancer	5.45e-06	2.25e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—MMP9—ovarian cancer	5.45e-06	2.25e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—PTEN—ovarian cancer	5.41e-06	2.23e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—PTEN—ovarian cancer	5.41e-06	2.23e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—IL6—ovarian cancer	5.41e-06	2.23e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—AKT1—ovarian cancer	5.28e-06	2.18e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—AKT1—ovarian cancer	5.28e-06	2.18e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—IL6—ovarian cancer	5.23e-06	2.16e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—IL6—ovarian cancer	5.23e-06	2.16e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—HRAS—ovarian cancer	5.22e-06	2.15e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—PTEN—ovarian cancer	5.07e-06	2.09e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—VEGFA—ovarian cancer	5.06e-06	2.08e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—HRAS—ovarian cancer	5.05e-06	2.08e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—HRAS—ovarian cancer	5.05e-06	2.08e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—STAT3—ovarian cancer	5.01e-06	2.06e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—NRAS—ovarian cancer	4.99e-06	2.06e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—IL6—ovarian cancer	4.99e-06	2.06e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—AKT1—ovarian cancer	4.99e-06	2.06e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—VEGFA—ovarian cancer	4.89e-06	2.02e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—VEGFA—ovarian cancer	4.89e-06	2.02e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—STAT3—ovarian cancer	4.84e-06	2e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—STAT3—ovarian cancer	4.84e-06	2e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—NRAS—ovarian cancer	4.83e-06	1.99e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—NRAS—ovarian cancer	4.83e-06	1.99e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—IL6—ovarian cancer	4.83e-06	1.99e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—IL6—ovarian cancer	4.83e-06	1.99e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—AKT1—ovarian cancer	4.83e-06	1.99e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—AKT1—ovarian cancer	4.83e-06	1.99e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—MAPK3—ovarian cancer	4.78e-06	1.97e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—PTEN—ovarian cancer	4.78e-06	1.97e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—PIK3CA—ovarian cancer	4.72e-06	1.95e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—MYC—ovarian cancer	4.65e-06	1.92e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—MAPK3—ovarian cancer	4.63e-06	1.91e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—MAPK3—ovarian cancer	4.63e-06	1.91e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—AKT1—ovarian cancer	4.61e-06	1.9e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—PIK3CA—ovarian cancer	4.57e-06	1.88e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—PIK3CA—ovarian cancer	4.57e-06	1.88e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—MAPK1—ovarian cancer	4.55e-06	1.88e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—EGFR—ovarian cancer	4.55e-06	1.88e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—MYC—ovarian cancer	4.5e-06	1.86e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—MYC—ovarian cancer	4.5e-06	1.86e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—AKT1—ovarian cancer	4.46e-06	1.84e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—AKT1—ovarian cancer	4.46e-06	1.84e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—MAPK1—ovarian cancer	4.4e-06	1.81e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—MAPK1—ovarian cancer	4.4e-06	1.81e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—EGFR—ovarian cancer	4.4e-06	1.81e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—EGFR—ovarian cancer	4.4e-06	1.81e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—KRAS—ovarian cancer	4.3e-06	1.77e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—KRAS—ovarian cancer	4.16e-06	1.71e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—KRAS—ovarian cancer	4.16e-06	1.71e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—PIK3CA—ovarian cancer	3.95e-06	1.63e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—AKT1—ovarian cancer	3.86e-06	1.59e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—TP53—ovarian cancer	3.82e-06	1.57e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—PIK3CA—ovarian cancer	3.82e-06	1.57e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—PIK3CA—ovarian cancer	3.82e-06	1.57e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—AKT1—ovarian cancer	3.73e-06	1.54e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—AKT1—ovarian cancer	3.73e-06	1.54e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—TP53—ovarian cancer	3.7e-06	1.52e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—TP53—ovarian cancer	3.7e-06	1.52e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—HRAS—ovarian cancer	3.65e-06	1.51e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—PIK3CA—ovarian cancer	3.58e-06	1.48e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—HRAS—ovarian cancer	3.53e-06	1.46e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—HRAS—ovarian cancer	3.53e-06	1.46e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—IL6—ovarian cancer	3.5e-06	1.44e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—IL6—ovarian cancer	3.38e-06	1.39e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—IL6—ovarian cancer	3.38e-06	1.39e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—PIK3CA—ovarian cancer	3.37e-06	1.39e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—AKT1—ovarian cancer	3.23e-06	1.33e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—AKT1—ovarian cancer	3.12e-06	1.29e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—AKT1—ovarian cancer	3.12e-06	1.29e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—AKT1—ovarian cancer	2.92e-06	1.21e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—AKT1—ovarian cancer	2.75e-06	1.14e-05	CbGpPWpGaD
